CVE-2024-9623 json
Incorrect Authorization in GitLab
published 2024-10-10 2 y ago modified 2026-09-10 59 d ago also BIT-gitlab-2024-9623 , EUVD-2024-50062
- cvss
- 4.9
- version 3.1, CNA
- cisa kev
- Not listed
- not in CISA's catalog
- epss
- 0.3%
- EPSS 0.3% chance of exploitation in 30 days, percentile 25%
- public exploits
- 0
- none known
Summary
An issue was discovered in GitLab CE/EE affecting all versions starting from 8.16 prior to 17.2.9, starting from 17.3 prior to 17.3.5, and starting from 17.4 prior to 17.4.2, which allows deploy keys to push to an archived repository.
Patch / fix
- bitnami gitlab 17.2.9, 17.3.5, 17.4.2
- GitLab GitLab 17.2.9, 17.3.5, 17.4.2
CISA SSVC
- Exploitation
- none
- Automatable
- no
- Technical impact
- partial
- Assessed
- 2 y ago
Exploit prediction
0.32% chance of exploitation in the next 30 days, higher than 25% of all scored CVEs (FIRST EPSS, 2026-11-08).
CVSS scores
| assigned by | version | score | vector |
|---|---|---|---|
| CNA | 3.1 | 4.9 | CVSS:3.1/AV:N/AC:L/PR:H/UI:N/S:U/C:N/I:H/A:N |
| NVD | 3.1 | 6.5 | CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:N/I:H/A:N |
| OSV | 3.1 | 4.9 | CVSS:3.1/AV:N/AC:L/PR:H/UI:N/S:U/C:N/I:H/A:N |
Affected packages
| ecosystem | package | affected | fixed in |
|---|---|---|---|
| bitnami | gitlab | >=8.16.0, <17.2.9 >=17.3.0, <17.3.5 >=17.4.0, <17.4.2 |
17.2.9 17.3.5 17.4.2 |
Affected products
- GitLab GitLab
Classification
- Weakness
-
- CWE-863 Incorrect Authorization
- Technology feeds
References
-
gitlab.com
/gitlab-org/gitlab/-/issues/459995
issue-tracking, permissions-required, broken-link, web
-
nvd.nist.gov
/vuln/detail/CVE-2024-9623
web
Sources
- CVE List CVE-2024-9623
- NVD CVE-2024-9623
- OSV BIT-gitlab-2024-9623
Fencer Vulns keeps one entry per vulnerability: the CVE id wins, then GHSA, and records that alias each other are merged, except that two CVEs always keep separate entries. The same data is available as JSON.
CPEs and fixed versions use Anchore's correction of NVD's data: Added CPE configurations because not yet analyzed by NVD.